Oceansix Future Paths Valuation
Is 5FC0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 5FC0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 5FC0 für die Bewertungsanalyse.
Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 5FC0 für die Bewertungsanalyse.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5FC0?
Other financial metrics that can be useful for relative valuation.
What is 5FC0's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$9.78m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5x |
Enterprise Value/EBITDA | -12.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 5FC0's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.1x | ||
IBU IBU-tec advanced materials | 1.2x | 19.1% | €57.5m |
SIM0 SIMONA | 0.6x | n/a | €411.0m |
BIG1 Bio-Gate | 1.4x | 25.7% | €9.2m |
BNN BRAIN Biotech | 1.2x | 12.4% |